Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Yesterday | ||
Jaguar Health Inc (JAGX) (Q2 2026) Earnings Call Highlights: Rare Disease Breakthroughs and ... Jaguar Health Inc (JAGX) reports groundbreaking MVID trial results and secures $18M in non-dilutive capital via FuturePak deal, despite a 60% revenue decline. | ||
Older | ||
MMT Newswires | ||
Jaguar Health Inc (JAGX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... Jaguar Health Inc (JAGX) reports a 5% revenue increase and a transformative partnership, despite facing operational losses and regulatory hurdles. | ||
BC-Most Active Stocks Tryhard Holdings Ltd. 28,780,305 8.03 | AAssociated Press Finance | |
Sector Update: Health Care Stocks Softer Late Afternoon Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health C | MMT Newswires | |
 Jaguar Health Inc (JAGX) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Ongoing Challenges Jaguar Health Inc (JAGX) reports a 4% revenue increase while navigating regulatory hurdles and net losses in Q3 2025. | ||
 Jaguar Health Completes Private Placement Deal Jaguar Health, Inc. (NASDAQ:JAGX) is among the best fundamentally strong penny stocks to buy right now. On September 9, 2025, Jaguar Health, Inc. (NASDAQ:JAGX) signed securities purchase agreements with some investors for the issuance and sale of nearly 951 shares of Series N Perpetual Preferred Stock. The funds from this $2.38 million private placement transaction […] | IInsider Monkey | |